Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
EXTERNAL PREPARATION FOR SKIN
Document Type and Number:
WIPO Patent Application WO/2020/116570
Kind Code:
A1
Abstract:
As an external preparation for skin having an antiinflammatory effect, provided is a combination of resolvin E1 with a glucocorticoid receptor agonist or a combination of resolvin E1 with a steroid categorized as group V (weak) or a steroid categorized as group IV (medium).

Inventors:
KABASHIMA KENJI (JP)
HONDA TETSUYA (JP)
SAWADA YU (JP)
Application Number:
PCT/JP2019/047652
Publication Date:
June 11, 2020
Filing Date:
December 05, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LYDIA OLEARY MEMORIAL PIAS DERMATOLOGICAL FOUND (JP)
International Classes:
A61K31/202; A61K31/4402; A61K31/573; A61K31/58; A61K31/7036; A61P17/00; A61P17/04; A61P17/06; A61P29/00; A61P43/00
Other References:
WATANABE, TOSHIYUKI: "Treatment of atopic dermatitis with a new external medicine containing DHA/EPA", ALLERGY IN PRACTICE, vol. 27, no. 12, 2007, pages 972 - 975
ARITA, MAKOTO ET AL.: "Novel chemical mediators in the resolution of inflammation, Resorbin and protectin derived from omega-3 fatty acids", PROTEIN, NUCLEIC ACID AND ENZYME, vol. 52, no. 4, 2007, pages 348 - 354
KIM, T. ET AL.: "Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2, 4- dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice", INTERNATIONAL IMMUNOPHARMACOLOGY, vol. 14, no. 4, 2012, pages 384 - 391, XP055715330, ISSN: 1567-5769
SAWADA, Y. ET AL.: "Resolvin E1 attenuates murine psoriatic dermatitis", SCIENTIFIC REPORTS, vol. 8, no. 1, 8 August 2018 (2018-08-08), pages 11873, XP055715331, ISSN: 2045-2322, DOI: 10.1038/s41598-018-30373-1
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: